Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361400 · ClinicalTrials.gov registry record
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1,387
- Enrollment target
NCT00361400: Completed study, sponsored by University of California, San Francisco.
NCT00361400 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1,387 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00361400 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1,387 participants
- Enrollment target
Study Summary
This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,387 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-09 |
What the finished NCT00361400 record still lists
NCT00361400 is an observational study that tracks outcomes without assigning an intervention. Its 1,387 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00361400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00361400 about?
NCT00361400 is a clinical study titled "Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study". This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.
What is the current status of trial NCT00361400?
This trial is currently completed. The enrollment target is 1,387 participants. The study started on 2005-08. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00361400?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- NCT05006131 · 1,395 participants
Pancreatic Cancer Screening for At-risk Individuals
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia